Gustav Hagen

Title: Gustav Hagen: Innovator in Cancer Detection and Angiogenesis Modulation

Introduction

Gustav Hagen is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the fields of cancer detection and angiogenesis modulation. With a total of 2 patents, his work is recognized for its innovative approaches to medical challenges.

Latest Patents

Hagen's latest patents include groundbreaking methods for modulating angiogenesis. One patent focuses on using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor. This invention provides methods for modulating angiogenesis by administering anti-angiogenic Ang-7 polypeptides to a subject. Additionally, he has developed an automatable rapid test for cancer detection based on telomerase (hTC) mRNA. This test utilizes specific primers and probes, along with a corresponding detection method and test kit.

Career Highlights

Gustav Hagen is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions that address critical health issues.

Collaborations

Hagen has collaborated with notable colleagues, including Maresa Wick and Dmitry Zubov. Their combined expertise contributes to the advancement of research and development in their respective fields.

Conclusion

Gustav Hagen's contributions to the fields of cancer detection and angiogenesis modulation highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical technology.